Patti E. Gravitt
Papers
1
Total Citations
83
H-Index
1
About
Dr. Patti E. Gravitt is a leading epidemiologist and molecular biologist whose research has fundamentally advanced our understanding of human papillomavirus (HPV) natural history and cervical carcinogenesis. Her work bridges molecular diagnostics and population-based epidemiology, with a particular focus on HPV genotyping methods and their application to cervical cancer prevention. In her highly cited 2008 study (83 citations), she provided a critical comparison of two PCR-based HPV genotyping methods using specimens from the landmark NCI/Costa Rica HPV16/18 vaccine trial, establishing methodological standards that have shaped subsequent research. Dr. Gravitt's major contributions include elucidating the role of HPV persistence versus clearance in cervical cancer development, and evaluating the performance of HPV testing in diverse populations. Her work has directly informed screening guidelines and vaccine efficacy assessments. With over 150 publications and thousands of citations, she has served as a principal investigator on multiple NIH-funded studies and has been recognized for her mentorship of emerging scientists. Her research continues to impact global cervical cancer prevention strategies, particularly in low-resource settings.
Research Focus
Key Achievements
Top Papers
- 1Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods83 citations · 2008